Evidence map›Paper›PMID 18557731›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2008

The classical complement pathway in transplantation: unanticipated protective effects of C1q and role in inductive antibody therapy.

K Csencsits, B E Burrell, G Lu, E J Eichwald, G L Stahl, D K Bishop

Open access · greenAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Complement Dependence of Murine Costimulatory Blockade-Resistant Cellular Cardiac Allograft Rejection.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2017
    Article
  6. Article
  7. Article
  8. Laminins affect T cell trafficking and allograft fate.The Journal of clinical investigation · 2014
    Article
  9. Fates of CD4+ T cells in a tolerant environment depend on timing and place of antigen exposure.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2012
    Article
  10. Genotypic diversity of complement component C4 does not predict kidney transplant outcome.Journal of the American Society of Nephrology : JASN · 2011
    Article
  11. Low-density array PCR analysis of reperfusion biopsies: an adjunct to histological analysis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2010
    Article
  12. Article
  13. Antibody-mediated rejection: emergence of animal models to answer clinical questions.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2010
    Review
  14. Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2010
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

K CsencsitsSection of General Surgery, Department of Surgery, University of Michigan School of Medicine, Ann Arbor, MI, USA. keri.c.smith@uth.tmc.edu
B E Burrell
G Lu
E J Eichwald
G L Stahl
D K Bishop
University of Michigan–Ann Arbor · USBrigham and Women's Hospital · USUniversity of Utah · US

Funding

MECHANISMS OF COMPLEMENT INDUCED ENDOTHELIAL DYSFUNCTIONR01HL056086 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI STAHL, GREGORY L · 1996 to 2014
$5.0M
Therapeutic Targets for Chronic Allograft RejectionR01HL070613 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BISHOP, D. KEITH · 2002 to 2014
$4.4M
MECHANISMS OF COMPLEMENT INDUCED MYOCARDIAL ISCHEMIAR01HL052886 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI STAHL, GREGORY L · 1999 to 2007
$3.5M
Roles of CD40 and CD40 Ligand in Allograft RejectionR01AI061469 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BISHOP, D. KEITH · 2004 to 2008
$1.6M
NHLBI NIH HHS R01 HL052886NHLBI NIH HHS R01 HL056086NHLBI NIH HHS R01 HL070613NHLBI NIH HHS R01 HL52886NHLBI NIH HHS R01 HL56086NIAID NIH HHS R01 AI061469
6 · The paper itself

Abstract

Though complement (C) deposition within the transplant is associated with allograft rejection, the pathways employed have not been established. In addition, evidence suggests that C-mediated cytolysis may be necessary for the tolerance-inducing activities of mAb therapies. Hence, we assessed the role of the classical C pathway in acute allograft rejection and its requirement for experimental mAb therapies. C1q-deficient (C1q-/-) recipients rejected allografts at a faster rate than wild-type (WT) recipients. This rejection was associated with exacerbated graft pathology but not with enhanced T-cell responses in C1q-/- recipients. However, the humoral response to donor alloantigens was accelerated in C1q-/- mice, as an early IgG response and IgG deposition within the graft were observed. Furthermore, deposition of C3d, but not C4d was observed in grafts isolated from C1q-/- recipients. To assess the role of the classical C pathway in inductive mAb therapies, C1q-/- recipients were treated with anti-CD4 or anti-CD40L mAb. The protective effects of anti-CD4 mAb were reduced in C1q-/- recipients, however, this effect did not correlate with ineffective depletion of CD4+ cells. In contrast, the protective effects of anti-CD40L mAb were less compromised in C1q-/- recipients. Hence, this study reveals unanticipated roles for C1q in the rejection process.

Indexed as

Complement Pathway, ClassicalAnimalsAntibodies, MonoclonalComplement C1qFemaleGraft RejectionImmunoglobulin GMiceMice, Inbred BALB CMice, Inbred C57BLSeverity of Illness IndexTransplantation ToleranceAntibodies, MonoclonalComplement C1qImmunoglobulin G

Identifiers

PMID18557731
PMCPMC2587427
OpenAlexW2116559039

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.